The blood test I booked with Randox (as part of their complete women’s health package) The test I took was the Everywoman Complete, which is designed to give you a more complete picture of your health rather than looking at one isolated result. It measures up to 150 data points across a pretty extensive range … [Read more…]
Over time, hematopoietic or blood stem cells can quietly acquire mutations that push them to divide just a little more aggressively, creating a larger group of clones in the bone marrow. In a fraction of people with this phenomenon, called clonal hematopoiesis of indeterminate potential — CHIP, for short — these cells can transform into … [Read more…]
An investigational therapy from Alnylam Pharmaceuticals did not significantly lower blood pressure in a key Phase 2 trial, raising questions about the benefit of the twice-a-year treatment as it enters late-stage testing. Among high-risk patients already taking at least two common hypertension treatments, a 300-mg dose of Alnylam’s zilebesiran led to a reduction in blood … [Read more…]
A study in rural China demonstrating the power of intensive blood pressure control clinched the deal. The large, cluster-randomized controlled trial convincingly demonstrated that well-controlled blood pressure — below 130/80 mm Hg — lowered the risk of dementia by 15% and cognitive impairment by 16%. That was the solid evidence reviewers needed to form the foundation … [Read more…]